Effective scours treatment depends on correcting dehydration and acidosis early. Here, Dr. Geoffrey Smith reviews ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...
IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...